1. The RNA-binding protein FMRP facilitates the nuclear export of N 6 -methyladenosine-containing mRNAs.
- Author
-
Hsu PJ, Shi H, Zhu AC, Lu Z, Miller N, Edens BM, Ma YC, and He C
- Subjects
- Active Transport, Cell Nucleus, Adenosine metabolism, Animals, Binding Sites, Cell Nucleus metabolism, Cerebral Cortex metabolism, Fragile X Mental Retardation Protein antagonists & inhibitors, Fragile X Mental Retardation Protein genetics, Fragile X Syndrome metabolism, Fragile X Syndrome pathology, HEK293 Cells, Humans, Mice, Mice, Inbred C57BL, Mice, Knockout, RNA Interference, RNA Stability, RNA, Messenger chemistry, RNA, Small Interfering metabolism, Adenosine analogs & derivatives, Fragile X Mental Retardation Protein metabolism, RNA, Messenger metabolism
- Abstract
N
6 -Methyladenosine (m6 A) is the most abundant post-transcriptional mRNA modification in eukaryotes and exerts many of its effects on gene expression through reader proteins that bind specifically to m6 A-containing transcripts. Fragile X mental retardation protein (FMRP), an RNA-binding protein, has previously been shown to affect the translation of target mRNAs and trafficking of mRNA granules. Loss of function of FMRP causes fragile X syndrome, the most common form of inherited intellectual disability in humans. Using HEK293T cells, siRNA-mediated gene knockdown, cytoplasmic and nuclear fractions, RNA-Seq, and LC-MS/MS analyses, we demonstrate here that FMRP binds directly to a collection of m6 A sites on mRNAs. FMRP depletion increased mRNA m6 A levels in the nucleus. Moreover, the abundance of FMRP targets in the cytoplasm relative to the nucleus was decreased in Fmr1 -KO mice, an effect also observed in highly methylated genes. We conclude that FMRP may affect the nuclear export of m6 A-modified RNA targets., (© 2019 Hsu et al.)- Published
- 2019
- Full Text
- View/download PDF